2023年7月11日，公司披露2022年年度权益分派实施公告，截至公告披露日，公司总股本为86,034,976 股，扣除回购专用证券账户中股份数515,201股，本次实际参与分配的股本数为85,519,775股，向全体股 东每股派发0元(含税)，以资本公积金向全体股东每10股转增4股，共计派发现金红利0元，共计转增 34,207,910股，本次转增后公司总股本为120,242,886股(最终转增股数及总股本数以中国证券登记结算有 限公司上海分公司最终登记结果为准)。 中自科技在上交所科创板上市公开发行股票2150.87万股，保荐机构为申万宏源证券（000562）承销保 荐有限责任公司，保荐代表人为杨晓、张仕源。 中自科技发行募集资金总额为15.25亿元，扣除发行费用后，募集资金净额为14.07亿元。中自科技最终 募集资金净额比原计划少5271.68万元。中自科技2021年10月18日披露的招股书显示，公司拟募集资金 14.60亿元，计划分别用于新型催化剂智能制造园区、汽车后处理装置智能制造产业园项目、国六b及以 上排放标准催化剂研发能力建设项目、氢能源燃料电池关键材料研发能力建设项目、补充流动资金。 中自科技 ...

中国经济网北京9月26日讯 爱克股份（300889.SZ）2025年半年报显示，2025年上半年，公司实现营业总收入5.31亿元，同比增长39.88%；归属于上市公 司股东的净利润-1203.36万元，上年同期-5627.39万元；归属于上市公司股东的扣非净利润-1382.47万元，上年同期-5917.65万元；经营活动产生的现金流量 净额为1729.50万元，上年同期为-3186.08万元。 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入(元) | 531,132,279.00 | 379,705,016.63 | 39.88% | | 归属于上市公司股东的净利润(元) | -12,033,618.50 | -56, 273, 864. 73 | 78.62% | | 归属于上市公司股东的扣除非经常性 损益的净利润(元) | -13,824,659.09 | -59,176,541.34 | 76.64% | | 经营活动产生的现金流量净额(元) | 17, 294, 976. 14 | -31,860,809.97 | 15 ...

Core Viewpoint - Pingao Co., Ltd. reported a revenue of 165.11 million yuan for the first half of 2025, marking a year-on-year increase of 7.21%, while the net profit attributable to shareholders was -15.81 million yuan, an improvement from -25.06 million yuan in the same period last year [1][2]. Financial Performance Summary - **Revenue**: The company achieved a revenue of 165.11 million yuan in the first half of 2025, up from 153.99 million yuan in the previous year, reflecting a growth of 7.21% [1][2]. - **Net Profit**: The net profit attributable to shareholders was -15.81 million yuan, compared to -25.06 million yuan in the same period last year, indicating a reduction in losses [1][2]. - **Net Profit Excluding Non-Recurring Items**: The net profit attributable to shareholders, excluding non-recurring items, was -19.06 million yuan, an improvement from -28.02 million yuan year-on-year [1][2]. - **Cash Flow**: The net cash flow from operating activities was -17.13 million yuan, compared to -112.09 million yuan in the same period last year, showing a significant reduction in cash outflow [1][2]. Historical Performance - **2024 Revenue**: For the year 2024, the company reported a revenue of 520.01 million yuan, a decrease of 4.81% from 546.26 million yuan in 2023 [3]. - **2024 Net Profit**: The net profit attributable to shareholders for 2024 was -64.06 million yuan, worsening from -10.68 million yuan in 2023 [3]. - **2024 Cash Flow**: The net cash flow from operating activities for 2024 was -112.84 million yuan, slightly improved from -120.03 million yuan in the previous year [3]. IPO and Fundraising - **IPO Details**: Pingao Co., Ltd. went public on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 30, 2021, issuing 28.26 million shares at a price of 37.09 yuan per share [3]. - **Fundraising Amount**: The total amount raised from the IPO was 1.048 billion yuan, with a net amount of 917 million yuan after deducting issuance costs [4]. - **Use of Funds**: The funds raised are intended for information technology innovation cloud platform, dedicated information service platform, Pingao Building construction, and to supplement working capital [4].

Core Viewpoint - The stock of Buchang Pharmaceutical (603858.SH) is currently in a state of decline, with a closing price of 18.67 yuan and a drop of 3.21% [1] Group 1: Company Overview - Buchang Pharmaceutical was listed on the Shanghai Stock Exchange on November 18, 2016, with an issuance of 69.8 million shares at an initial price of 55.88 yuan [1] - The total amount raised from this issuance was 390,042.40 thousand yuan, with a net amount of 367,143.57 thousand yuan after deducting issuance costs [1] Group 2: Fund Utilization - The funds raised are intended for the construction of a cardiovascular drug production base in Shaanxi, as well as for supplementing working capital and repaying bank loans [1] - The total issuance costs for this public offering amounted to 22,898.83 thousand yuan, with the underwriter and sponsor, CITIC Securities, receiving 21,974.80 thousand yuan in fees [1]

Core Viewpoint - Huaru Technology (301302.SZ) reported a revenue of 103 million yuan in the first half of 2025, reflecting a year-on-year growth of 3.85%, but the company faced significant net losses [1][2]. Financial Performance Summary - The company's revenue for the first half of 2025 was 103,010,618.18 yuan, up 3.85% from 99,188,699.13 yuan in the same period last year [2]. - The net profit attributable to shareholders was -83,809,104.70 yuan, a decline of 27.58% compared to -65,692,487.89 yuan in the previous year [2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -89,302,468.62 yuan, down 24.61% from -71,664,102.32 yuan year-on-year [2]. - The net cash flow from operating activities was -200,673,289.27 yuan, compared to a positive cash flow of 225,148,034.65 yuan in the same period last year [2]. Previous Year Comparison - In 2024, the company achieved a revenue of 249,350,372.30 yuan, a decrease of 31.12% from 362,028,349.15 yuan in 2023 [3]. - The net profit attributable to shareholders for 2024 was -354,300,678.53 yuan, worsening by 59.86% from -221,634,892.18 yuan in 2023 [3]. - The net profit after deducting non-recurring gains and losses was -367,131,158.41 yuan, a decline of 51.81% from -241,840,512.88 yuan year-on-year [3]. - The net cash flow from operating activities in 2024 was -94,385,500.60 yuan, compared to -245,801,323.36 yuan in the previous year [3]. Company Background - Huaru Technology was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on June 23, 2022, with an initial stock issuance of 26.37 million shares at a price of 52.03 yuan per share [4]. - The total amount raised from the initial public offering was 137,203.11 million yuan, with a net amount of 127,524.55 million yuan, exceeding the original plan by 47,524.55 million yuan [4]. - The company plans to use the raised funds for various projects, including a new generation of combat systems and a collaborative design and simulation testing platform [4].

Core Viewpoint - Jiu Ri New Materials (688199.SH) reported a decline in revenue and net profit for the first half of 2025, while showing significant improvement in cash flow from operating activities [1][2]. Financial Performance - The company achieved operating revenue of 713.50 million yuan in the first half of 2025, a decrease of 7.11% compared to the same period last year [2]. - The net profit attributable to shareholders was -9.06 million yuan, an improvement from -12.88 million yuan in the previous year [1][2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -10.17 million yuan, compared to -18.44 million yuan in the same period last year [2]. - The net cash flow from operating activities was 39.84 million yuan, showing a significant increase of 726.08% year-on-year [1][2]. Historical Context - Jiu Ri New Materials was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 5, 2019, with an initial public offering price of 66.68 yuan per share [3]. - The total amount raised from the IPO was 185.42 million yuan, with a net amount of 170.93 million yuan after expenses [3]. - The company planned to use the raised funds for projects related to the production of light-curing materials and technology research [3]. Shareholder Information - In 2024, the company announced a stock dividend distribution plan, where shareholders would receive 4.9 additional shares for every 10 shares held, without cash dividends or bonus shares [4].

Financial Performance - In the first half of 2025, the company achieved operating revenue of 195 million CNY, representing a year-on-year increase of 15.19% [1][3] - The net profit attributable to shareholders was -29.39 million CNY, a decrease of 314.35% compared to the same period last year [1][3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -33.36 million CNY, a decline of 484.34% year-on-year [1][3] - The net cash flow from operating activities was -47.63 million CNY, worsening from -22.04 million CNY in the previous year [1][3] Initial Public Offering (IPO) Details - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 2, 2022, with a total fundraising amount of 150.99 million CNY [4] - The net amount raised was 137.09 million CNY, exceeding the original target by 96.74 million CNY [4] - The company originally planned to raise 40.34 million CNY for product development and working capital [4] - The underwriting fees for the IPO totaled 13.91 million CNY, with the lead underwriter being Guotai Junan Securities [4] Stock Performance - The company's stock is currently trading below its initial offering price, indicating a state of "broken issue" [1][4] - A stock split occurred on May 9, 2023, with a distribution of 4.8 additional shares for every 10 shares held, along with a pre-tax dividend of 4.29 CNY per share [4]

Core Viewpoint - Canrui Technology (688061.SH) reported a revenue of 294 million RMB in the first half of 2025, reflecting an 8.57% year-on-year growth, but faced a net loss attributable to shareholders of 26.82 million RMB [1][3]. Financial Performance - The company's operating revenue for the first half of 2025 was 294,547,040.65 RMB, compared to 270,373,369.02 RMB in the same period last year, marking an increase of 8.57% [3]. - The total profit for the period was -27,511,475.01 RMB, worsening from -15,374,245.09 RMB year-on-year [3]. - The net profit attributable to shareholders was -26,823,513.45 RMB, compared to -5,979,501.85 RMB in the previous year [3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -40,867,710.45 RMB, compared to -24,927,533.52 RMB last year [3]. - The net cash flow from operating activities was -51,342,833.07 RMB, an improvement from -65,000,913.99 RMB in the same period last year [3]. Historical Context - Canrui Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 18, 2022, with an initial offering price of 112.69 RMB per share [4]. - The stock opened at 100.68 RMB on its first trading day, indicating a decline from its offering price and has remained in a state of decline since then [4]. - The total funds raised from the initial public offering amounted to 217,230.26 million RMB, with a net amount of 199,997.60 million RMB after deducting issuance costs [4]. - The company planned to use the raised funds for high-performance sensor R&D, power management chip R&D, specialized integrated circuit packaging, R&D center construction, and working capital supplementation [4]. Equity Distribution - In 2022, the company announced a cash dividend of 0.55 RMB per share and a capital reserve transfer of 0.49 shares for every share held, resulting in a total cash distribution of 42,408,835.70 RMB and a share increase of 37,782,417 shares [5][6]. - The total share capital after the distribution was 114,889,391 shares, with the record date for the distribution set for June 19, 2023, and the ex-dividend date on June 20, 2023 [6].

Group 1 - The core viewpoint of the news is that Zhongke Weizhi (688211.SH) reported a significant decline in revenue and net profit for the first half of 2025, indicating financial challenges [1] - The company achieved operating revenue of 1.002 billion yuan, a year-on-year decrease of 25.40% [1] - The net profit attributable to shareholders was -62.48 million yuan, compared to a profit of 4.53 million yuan in the same period last year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -84.99 million yuan, worsening from -32.54 million yuan year-on-year [1] - The net cash flow from operating activities was 56.82 million yuan, down from 153 million yuan in the previous year [1] Group 2 - From 2022 to 2024, Zhongke Weizhi's operating revenue was 2.315 billion yuan, 1.957 billion yuan, and 2.474 billion yuan respectively [1] - The net profit attributable to shareholders for the same period was -119 million yuan, 20.85 million yuan, and -847.51 million yuan [1] - The net profit after deducting non-recurring gains and losses was -191 million yuan, -44.98 million yuan, and -133 million yuan [1] - The net cash flow from operating activities for these years was -37.44 million yuan, 622 million yuan, and 261 million yuan [1] Group 3 - Zhongke Weizhi was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 26, 2021, with an issuance of 33 million shares at a price of 90.20 yuan per share [1] - The total amount raised from the initial public offering (IPO) was 2.977 billion yuan, with a net amount of 2.749 billion yuan after deducting issuance costs [2] - The final net amount raised was 1.409 billion yuan more than originally planned [2] - The IPO expenses totaled 228 million yuan, including underwriting and sponsorship fees of 208 million yuan [2]

Core Insights - Tianyi New Materials (688033.SH) reported a revenue of 422.92 million yuan for the first half of 2025, a year-on-year decrease of 17.26% [1][2] - The net profit attributable to shareholders was -209.35 million yuan, an improvement from -492.79 million yuan in the same period last year [1][2] - The net cash flow from operating activities was 160.33 million yuan, showing a significant increase of 328.42% year-on-year [1][2] Financial Performance Summary - Revenue for the first half of 2025: 422,920,712.86 yuan, down from 511,174,885.23 yuan, a decrease of 17.26% [2] - Total profit for the period: -181,772,424.04 yuan, compared to -551,263,661.64 yuan in the previous year [2] - Net profit attributable to shareholders: -209,354,574.17 yuan, improved from -492,785,725.22 yuan [2] - Net profit after deducting non-recurring gains and losses: -224,775,732.09 yuan, improved from -507,881,643.33 yuan [2] - Operating cash flow: 160,325,903.52 yuan, up 328.42% from 37,422,328.94 yuan [2] Historical Financial Data - For the year 2024, the company reported a revenue of 763.05 million yuan, a significant decrease of 63.85% from 2.11 billion yuan in 2023 [3] - The net profit attributable to shareholders for 2024 was -1.50 billion yuan, a decrease of 1138.31% compared to a profit of 144.02 million yuan in 2023 [3] - The net profit after deducting non-recurring gains and losses for 2024 was -1.59 billion yuan, down 2114.15% from 79.17 million yuan in 2023 [3] - Operating cash flow for 2024 was 288.63 million yuan, compared to -496.51 million yuan in 2023 [3] Company Background - Tianyi New Materials was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 22, 2019, with an initial issuance of 47,880,000 shares at a price of 20.37 yuan per share [3] - The company's stock has been in a state of decline since reaching a peak of 64.80 yuan shortly after its listing [3] - The total amount raised from the company's two fundraising rounds is 3.294 billion yuan [6]